Bradycardia in a pediatric population after sugammadex administration: case series

Sugammadex is a distinctive neuromuscular reversal drug that acts by encapsulating the neuromuscular relaxant molecule and dislodging it from its site of action. Sugammadex has been approved for pediatric patients over 2 years of age. Although arrhythmias have been reported, there is no report of ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvalho, Erica Viviana Guimarães, Caldas, Sandra Maria Carvalho, Costa, Dinis Fernando Pereira Pinheiro Machado da, Gomes, Cristina Maria Graça Peixoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801215/
https://www.ncbi.nlm.nih.gov/pubmed/35121059
http://dx.doi.org/10.1016/j.bjane.2021.12.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801215/
https://www.ncbi.nlm.nih.gov/pubmed/35121059
http://dx.doi.org/10.1016/j.bjane.2021.12.011

Ejemplares similares